Clinical Trials Directory

Trials / Completed

CompletedNCT04652947

MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
University Hospital, Angers · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Compare diagnostic MRI performance of gadoteric acid, gadoxetic acid and P03277 for suspected CHC nodules less than 3 cm, using LIRADS criteria

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRI diagnosticno intervention, patient only have MRI

Timeline

Start date
2016-12-07
Primary completion
2017-10-26
Completion
2017-10-26
First posted
2020-12-03
Last updated
2020-12-03

Source: ClinicalTrials.gov record NCT04652947. Inclusion in this directory is not an endorsement.

MR Quality + Diagnostic Performance for CHC Diagnosis - Gadoxetic Acid, Gadoteric Acid and P03277 Comparison (NCT04652947) · Clinical Trials Directory